Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial (Q97419712)
Jump to navigation
Jump to search
scientific article published on 29 April 2020
Language | Label | Description | Also known as |
---|---|---|---|
English | Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial |
scientific article published on 29 April 2020 |
Statements
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial (English)
Nir Kleinmann
Surena F Matin
Phillip M Pierorazio
John L Gore
Ahmad Shabsigh
Brian Hu
Karim Chamie
Guilherme Godoy
Scott Hubosky
Marcelino Rivera
Michael O'Donnell
Marcus Quek
Jay D Raman
John J Knoedler
Douglas Scherr
Joshua Stern
Christopher Weight
Alon Weizer
Michael Woods
Hristos Kaimakliotis
Angela B Smith
Jennifer Linehan
Jonathan Coleman
Mitchell R Humphreys
Raymond Pak
David Lifshitz
Michael Verni
Mehrad Adibi
Mahul B Amin
Elyse Seltzer
Ifat Klein
Marina Konorty
Dalit Strauss-Ayali
Gil Hakim
Mark Schoenberg